Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

703
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
703
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

562
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
562
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

570
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
570
Positron Emission Tomography01:29

Positron Emission Tomography

7.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Dynamic PSMA-PET for metastasis profiling in prostate cancer: a potential new approach to predict response to therapy.

European journal of nuclear medicine and molecular imaging·2026
Same author

Dynamic PSMA-PET for metastasis profiling in prostate cancer: a potential new approach to predict response to therapy.

European journal of nuclear medicine and molecular imaging·2026
Same author

Radioligand Therapy with Radiolabeled Somatostatin Analogues in Metastatic Bronchial Carcinoid: an Impressive Response.

Nuclear medicine and molecular imaging·2026
Same author

Molecular Imaging Advances in Endometriosis: The Promise of Radiopharmaceuticals.

Molecules (Basel, Switzerland)·2026
Same author

One scan, many stories: deep learning for signal separation in multi-tracer PET imaging.

Physics in medicine and biology·2025
Same author

Targeting Glypican-3 in Liver Cancer: Groundbreaking Preclinical and Clinical Insights.

Biomedicines·2025

Related Experiment Video

Updated: Mar 12, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

14.5K

Colorectal Cancer: A Landscape of New Potential Radiopharmaceuticals.

Veronica Serena Cabitza1, Pier Cesare Capponi2, Irene Brusa1

  • 1Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Molecular Diagnosis & Therapy
|March 11, 2026
PubMed
Summary
This summary is machine-generated.

Positron emission tomography (PET) with [18F]FDG shows limitations in colorectal cancer diagnosis due to false positives. Novel radiotracers are being developed to improve accuracy and patient outcomes in colorectal cancer detection.

More Related Videos

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
12:24

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers

Published on: July 17, 2012

12.9K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

9.5K

Related Experiment Videos

Last Updated: Mar 12, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

14.5K
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
12:24

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers

Published on: July 17, 2012

12.9K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

9.5K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiochemistry

Background:

  • Positron emission tomography (PET) combined with computed tomography (CT) using 2-deoxy-2-[fluorine-18]fluoro-D-glucose ([18F]FDG) is a valuable non-invasive tool in oncology.
  • However, [18F]FDG-PET's utility in colorectal cancer (CRC) is limited by its pharmacokinetic and metabolic characteristics, leading to restricted use in initial diagnosis and staging.
  • Challenges include false-positive results from non-malignant conditions like inflammatory bowel disease, hindering reliable distinction between benign and malignant lesions.

Purpose of the Study:

  • To review the current limitations of [18F]FDG-PET in colorectal cancer imaging.
  • To explore the development of novel radiotracers for enhanced specificity and accuracy in PET imaging for colorectal cancer.
  • To assess the potential of emerging radiopharmaceuticals in clinical evaluation phases.

Main Methods:

  • Review of current literature on [18F]FDG-PET in colorectal cancer.
  • Investigation of novel radiolabeled probes ([18F], [68Ga], [11C], [64Cu]) for colorectal cancer detection.
  • Analysis of preliminary clinical evaluation data for emerging radiopharmaceuticals like [68Ga]Ga-HNI01 and [68Ga]Ga-FAPI-04.

Main Results:

  • [18F]FDG-PET is primarily used for treatment response assessment and surveillance in colorectal cancer, not routine diagnosis or staging.
  • False-positive findings in [18F]FDG-PET imaging of colorectal cancer are common due to uptake in inflammatory conditions.
  • Novel radiotracers show promise in preclinical studies, with [68Ga]Ga-HNI01 and [68Ga]Ga-FAPI-04 advancing to early clinical trials.

Conclusions:

  • Significant limitations exist for [18F]FDG-PET in colorectal cancer diagnosis, necessitating improved imaging agents.
  • Development of new radiotracers targeting specific molecular pathways offers potential for enhanced accuracy and specificity.
  • Further large-scale clinical trials are crucial to validate the efficacy and safety of novel PET agents for improved colorectal cancer detection and characterization.